Procurement notices · Find a Tender + Contracts Finder

Notices

Every UK public-sector procurement notice in one board — open opportunities, closed tenders, awards, and pre-market signals. Filter by deadline, value or CPV, and save your search as an alert.

Closing 24h

Open notices

Closing this week

Don’t miss

Open · all

70,824

Live opportunities

Posted · 24h

272

New notices

Posted · 30d

9,084

All notice types

Awarded · 7d

1,152

Market signal

ActiveView: Closed Clear all

165,209 noticesclosed · sorted by publication date

Page 46 of 8261

Time to close

Value

Type

Buyer

Notice

CLOSED

13 Mar

£100k

Estimated

Closed

Kier Transportation - CP7 NWC

Manchester International Airport - Compound Set Up Electrical

Construction work· Published 23 Feb

Notice peek

ClosedFTS · 03e3a9

NHS Scottish National Blood Transfusion Service (SNBTS) Cell Therapy eSolution

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Status

cancelled

Estimated

—

Services

Published

08 Apr 2025

Key facts

Notice ID: ocds-h6vhtk-03e3a9
CPV code: 72000000 · IT services
Contract type: services
Source: Find a Tender

Timeline

Published
08 Apr 2025

Description

The Common Services Agency (more commonly known as NHS National Services Scotland or NSS) (“NSS”), acting through its directorate the Scottish National Blood Transfusion Service (“SNBTS”), is undertaking the procurement of two electronic eSolutions that will allow onboarding of novel cell therapy projects from research centres, facilitating project development and eventual translation into a Good Manufacturing Practice (GMP) environment. The two eSolution systems between them will encompass five Phases across an entire product life cycle of an Advanced Therapeutic from development through to clinical use. System 1 will include onboarding of research documentation, development, and initial stages of technology transfer (Phase 1 and Phase 2). System 2 will include the final stages of technology transfer into GMP validation, batch manufacture and have report producing capabilities to allow for quality approval then release/certification for patient use (Phase 3, 4 and 5). The solutions must be provided using a Software as a Service (SaaS) model. Further information can be found within the Invitation to Tender (ITT) and appendices located on PCS-Tender.